Clinical Trial Update: Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the pharmacokinetics and safety of carfilzomib in patients with advanced solid tumors or hematologic malignancies and hepatic impai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• Carfilzomib (carfilzomib)

Snippet

Sponsor: Amgen | Conditions: Solid Tumors, Hematologic Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2016-10-21